Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, Moller HJ (2007) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 8: 67–104PubMedCrossRef

Bishop FL, Adams AE, Kaptchuk TJ, Lewith GT (2012) Informed consent and placebo effects: a content analysis of information leaflets to identify what clinical trial participants are told about placebos. PLoS One 7: e39661CrossRef

Brody H, Colloca L, Miller FG (2012) The placebo phenomenon: implications for the ethics of shared decision-making. J Gen Intern Med 27(6): 739–42PubMedCrossRef

Chen JA, Papakostas GI, Youn SJ, Baer L, Clain AJ, Fava M, Mischoulon D (2011) Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group. J Clin Psychiatry 72: 1669–1676PubMedCrossRef

Colloca L, Miller FG (2011) Role of expectations in health. Curr Opin Psychiatry 24: 149–155PubMedCrossRef

Drake RE, Cimpean D, Torrey WC (2009) Shared decision making in mental health: prospects for personalized medicine. Dialogues Clin Neurosci 11: 455–463PubMed

Ernst E (2007) Placebo: new insights into an old enigma. Drug Discov Today 12: 413–418PubMedCrossRef

Ernst E, Resch KL (1995) Concept of true and perceived placebo effects. BMJ 311: 551–553PubMedCrossRef

Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J (2010) Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303: 47–53PubMedCrossRef

Gross CP, Mallory R, Heiat A, Krumholz HM (2002) Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med 137: 10–16PubMedCrossRef

Henkel V, Casaulta F, Seemuller F, Krahenbuhl S, Obermeier M, Husler J, Moller HJ (2012) Study design features affecting outcome in antidepressant trials. J Affect Disord 141(2–3): 160–7

Kelley JM, Kaptchuk TJ, Cusin C, Lipkin S, Fava M (2012) Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychother Psychosom 81: 312–314PubMedCrossRef

Kennedy SH, Lam RW, Parikh SV, Patten SB, Ravindran AV (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord 117 (Suppl. 1): S1–2

Krell HV, Leuchter AF, Morgan M, Cook IA, Abrams M (2004) Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry 65: 1174–1179PubMedCrossRef

Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 117 (Suppl. 1): S26–43